Elevance Health stock gains after reaffirmed 2026 earnings guidance

Published on 09/11/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock rose after the company reaffirmed its 2026 adjusted earnings floor on September 10, 2026, ahead of investor meetings. The shares closed near USD 416 with a gain of more than 5 percent versus the prior session.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health stock (ISIN US2855211023) climbed sharply as the managed care group reaffirmed its full year 2026 earnings guidance ahead of a series of investor meetings, with the shares changing hands around USD 416.54 as of September 11, 2026 after a more than 5 percent gain compared with the previous close.

Guidance reaffirmed for 2026 earnings

According to Benzinga on September 10, 2026, Elevance Health reaffirmed an adjusted earnings floor of USD 20.10 per diluted share for fiscal 2026, only slightly below the USD 20.26 per share that analysts had been expecting for the year.

As the same report notes, Elevance Health indicated that this floor includes roughly USD 6.90 per share of unfavorable one time items; excluding these, the company expects underlying adjusted earnings to exceed USD 27.00 per diluted share in 2026, which is above the USD 26.91 consensus estimate cited by Benzinga.

Stock performance and technical backdrop

Per an overview of S&P 500 movers from The Economic Times as of September 11, 2026, Elevance Health shares were quoted at USD 416.54, representing a daily gain of 5.38 percent on the New York Stock Exchange and placing the stock among the day’s top performers in the S&P 500.

In its technical commentary, Benzinga highlighted that the Elevance Health share price was running about 4 percent above its 20 day moving average and nearly 16 percent above its 200 day moving average as of September 10, 2026, indicating a solid upward trend in the stock over recent months.

The same analysis pointed to a resistance level around USD 436, just below the stock’s 52 week high of USD 436.24, and a support zone near USD 391, close to the 100 day moving average at USD 391.14, suggesting that the current price of USD 416.54 sits roughly midway between that support region and the recent high.

Analyst sentiment and valuation context

According to MarketBeat on September 10, 2026, Elevance Health is currently covered by twenty three research analysts, of whom fifteen rate the stock as Buy and eight as Hold, resulting in an average rating characterized as Moderate Buy.

The same MarketBeat overview reported an average analyst price target of USD 440.90 for Elevance Health as of September 10, 2026, implying an upside of around 5.9 percent from the prevailing share price of about USD 416.54 at that time.

Complementing the sell side view, GuruFocus on September 10, 2026, noted that Elevance Health carried a GF Score of 90 out of 100, with the stock trading at USD 416.54, roughly 13.8 percent below the platform’s estimated fair value of USD 483.43.

Upcoming investor events and broader sector setting

As TipRanks reported on September 10, 2026, Elevance Health shares have also been supported by anticipation of the company’s planned appearance at an Oppenheimer hosted investor meeting scheduled for September 15, 2026, where management is expected to discuss strategy and capital allocation.

The same TipRanks note cited a year to date price performance of 14.38 percent for Elevance Health as of early September 2026, underscoring that the stock’s recent move following the guidance reaffirmation comes on top of a double digit gain over the course of the year.

In a broader sector context, an update from MarketsDay on September 11, 2026, noted that the health care sector showed relative defensive resilience, with managed care leaders such as Elevance Health contributing selective gains despite volatility linked to rising energy prices and interest rate concerns.

Elevance Health stock price and key metrics

On the New York Stock Exchange, Elevance Health stock last closed at approximately USD 416.54 on September 11, 2026, after a session gain of about 5.38 percent compared with the prior day’s close, with the price move helping to narrow the gap to the 52 week high of USD 436.24 while remaining well above the cited support area near USD 391.